Home › NCT06328127

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT
* Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
* Access to a basic telephone

Exclusion Criteria:

* Patients who underwent allogeneic HSCT for benign hematologic conditions
* Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures

About the study

This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.

What is being tested

• PATH (behavioral)

Sponsor: Brigham and Women's Hospital · Participants: 400 · Started: Dec 17, 2024

Contact the study team

• Hermioni Amonoo, MD, MPP, MPH · Phone: 617-525-7472

Official record on ClinicalTrials.gov — NCT06328127

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.